Banks to offer financial help to cancer patients

For a large proportion of patients ringing the Macmillan helpline, it is not their health they wish to discuss, but their finances. According to recent research by Macmillan, most cancer patients are nearly £7,000 a year worse off because of their cancer diagnosis, and the banks are doing very little to help them. Many patients […]

read more

UK cancer survival rates lag behind other European countries

A recent study, commissioned by the Association of the British Pharmaceutical Industry (ABPI), reports that British cancer patients have the worst survival rates in Europe for nine out of ten major cancers.  The study found the UK had ‘below average rates of five-year survival in diseases such as bowel, lung, breast, ovarian, prostate and kidney cancer, […]

read more

A test to gauge recurrence risk for kidney cancer is unable to predict which patients will benefit from adjuvant therapy

An American company called Genomic Health has been collaborating with Pfizer over the past 10 years to develop a 16-gene expression test to determine the chances of recurrence of kidney cancer after surgery. The test was validated in a study, which was published in The Lancet Oncology in 2015. The validation study showed that the […]

read more

Office for National Statistics publishes latest cancer survival data

The Office for National Statistics (ONS) has published the latest data on cancer survival in England for both adults and children, presented by stage of disease at diagnosis and followed up to 2016. Both one- and five-year survival data are presented, and ten-year survival data for some cancers. One-year survival was highest for melanoma of […]

read more

Potential molecular scoring method for predicting survival in metastatic kidney cancer

A recent study presented at the American Urology Association (AUA) Annual Meeting in Boston last month, described a new molecular (genetic) scoring method that could be used to predict survival in people with metastatic kidney cancer. There has been rapid adoption by researchers of using sets of genes, proteins, genetic variants or other variables (molecular signatures) […]

read more

1000s of lives could be saved each year if the UK emulates healthcare systems of high-income countries

The Institute of Economic Affairs (IEA), a free market think-tank, has released data showing that if UK cancer patients were treated in Germany or Belgium rather than by the NHS, more than 13,000 lives would be saved each year. The report highlights that the 5-year survival rate for breast, lung and bowel cancer in the […]

read more

One-year cancer survival data published for CCGs in England

The Office for National Statistics (ONS) has published new statistics on 1-year cancer survival rates across all 209 Clinical Commissioning Groups (CCGs) in England. The data are presented for all cancers combined, and for breast, colorectal, and lung cancers in adults diagnosed in the period 1999 to 2014 and followed-up to 2015. The key points are: […]

read more
Showing 61 to 67 of 67 results
  TOP